Media stories about LivaNova PLC (NASDAQ:LIVN) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LivaNova PLC earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news articles about the company an impact score of 0 out of 100, meaning that recent press coverage is extremely unlikely to have an impact on the company’s share price in the next several days.
LivaNova PLC (LIVN) opened at 61.63 on Tuesday. The stock has a 50 day moving average price of $59.31 and a 200-day moving average price of $51.85. The stock’s market capitalization is $3.01 billion. LivaNova PLC has a 12-month low of $40.83 and a 12-month high of $63.21.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings results on Wednesday, May 3rd. The company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. LivaNova PLC had a negative net margin of 0.92% and a positive return on equity of 8.77%. The firm had revenue of $285.10 million during the quarter. On average, equities analysts anticipate that LivaNova PLC will post $3.11 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.thestockobserver.com/2017/07/18/livanova-plc-livn-getting-somewhat-favorable-media-coverage-study-shows-updated-updated.html.
In other LivaNova PLC news, Director Sharon O’kane acquired 1,000 shares of LivaNova PLC stock in a transaction that occurred on Tuesday, May 23rd. The stock was bought at an average price of $58.58 per share, with a total value of $58,580.00. Following the completion of the purchase, the director now directly owns 1,000 shares of the company’s stock, valued at approximately $58,580. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Hugh M. Morrison sold 3,215 shares of the business’s stock in a transaction that occurred on Friday, May 5th. The stock was sold at an average price of $55.89, for a total transaction of $179,686.35. Following the completion of the transaction, the director now directly owns 2,000 shares of the company’s stock, valued at approximately $111,780. The disclosure for this sale can be found here. Insiders have sold 5,215 shares of company stock valued at $298,976 in the last ninety days. Insiders own 0.28% of the company’s stock.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.